Ludovic Apoux

Suggest Changes
Learn More
BACKGROUND The inhaled corticosteroid fluticasone furoate (FF) in combination with the long-acting β2 agonist vilanterol (VI) is in development for asthma and chronic obstructive pulmonary disease.(More)
  • 1